PCMA Statement on the Administration’s Blueprint on Drug Pricing
July 16, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement today on the Administration’s...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
July 16, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is releasing new research showing that premiums would rise by over 50 percent...
Massachusetts Legislation Increases Drug Costs
July 06, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on health reform legislation...
Drug Manufacturers Continue to Significantly Increase Prescription Drug Prices
July 05, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on reports of yet...
PCMA Statement on Reducing Prescription Drug Prices
June 26, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the Senate...
PCMA Applauds House Passage of Bill Curbing Opioid Epidemic
June 22, 2018
(Washington, D.C.) — Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6),...
PCMA Applauds Judiciary Committee on Passage of CREATES Act to Help Lower Drug Prices
June 14, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the Senate Judiciary Committee’s...
PCMA Statement on HELP Committee Hearing on President’s Blueprint to Lower Drug Prices
June 12, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the Health, Education, Labor and Pensions Committee...
Federal Circuit Court Unanimously Strikes Down Arkansas Mandate Restricting PBM Tools
June 08, 2018
(Washington, D.C.) — The Eighth Circuit Court of Appeals, in a unanimous three judge decision, today ruled in favor of the...
PCMA Statement on New OIG Medicare Part D Report
June 04, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a Medicare Part D report released today...
May 29, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today on the Congressional Budget Office’s (CBO) $43...
PCMA Statement on New Avalere Study Examining Generic Drugs in Medicare
May 22, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement today on a new Avalere study, Generic...